Overview
Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children
Status:
Unknown status
Unknown status
Trial end date:
2009-03-01
2009-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study aims to evaluate mitomycin C as an adjunct to endoscopic treatment of esophageal strictures. This is a crossover, controlled, clinical trial in which children with esophageal stricture will be randomized in two groups to receive either topical mitomycin or no additional treatment during standard esophageal dilation session.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Federal University of São PauloTreatments:
Mitomycin
Mitomycins
Criteria
Inclusion Criteria:- children with esophageal strictures
- and dysphagia
- or stricture preventing endoscope to pass over it.
Exclusion Criteria:
- congenital esophageal stricture
- stricture associated to eosinophilic esophagitis